If you have been diagnosed with cancer you probably have thought about joining a clinical trial. But if you’re like most patients, you have questions.
When you’re receiving cancer treatment, anything that makes you more comfortable is a good thing. Here’s what to expect if you are considering having a port implanted.
Hair loss is one of the top concerns for women undergoing chemotherapy for breast cancer. But a new, special device may help some women keep their hair, early results of a new study say.
Immunotherapy, alone or in combination with other treatments, can help your body fight harder against advanced lung cancer. For some people, it gets results when other treatments have failed.
Getting through cancer treatment successfully is something to celebrate. To stay in good health, doctors say you need to watch for other symptoms, including vision changes, headaches and problems with balance.
Immunotherapy — drugs that use your body’s immune system to kill diseases — has become an important tool for treating some types of cancer. And now, people with advanced bladder cancer have an immunotherapy option.
New research is spurring exciting developments in the microbiome, the trillions of bacteria that make up communities living in our bodies. Scientists are exploring how being aware of imbalances in these bacteria could lead to new diagnoses and treatments. All this could have a positive impact on people’s health.
New recommendations released last year by the American Cancer Society advise most women to get fewer mammograms, not more. What’s going on here?
People have a lot of misconceptions about cancer clinical research trials. They might think patients mostly take sugar pills instead of receiving actual treatment. Or they may think clinical research studies are only for people who have no other options. Learn the truth.
Within a few years of using prostate-specific antigen (PSA) tests, we saw an amazing shift: By the mid-1990s, most men newly diagnosed with prostate cancer were curable. Since then, studies have shown that while PSA screening reduces a man’s likelihood of dying from prostate cancer, it does not reduce overall mortality. The problem has been with how we use PSA tests.